| ID | 348 |
|---|
| No | 348 |
|---|
| Brand Name | ERDACARE |
|---|
| Ingredients | ERDAFITINIB 3 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | STORE BELOW 30C |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 56'S |
|---|
| Dispensing Category | Prescription only |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | ANTINEOPLASTIC |
|---|
| Indications | TREARMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA THAT HAS SUSCEPTIBLE FGFR 3 OR FGFR2 GENETIC ALTERATION AND PROGRESSD DURING OR FOLLOWING AT LEAST ONE LINE OF PRIOR PLATINUM-CONTAINING CHEMOTHERAPY INCLUDING WITHIN 12 MONTHS OF NEOADJUVANT OR ADJUVANT PLATINUM-CONTAINING CHEMOTHERAPY |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | WHITISH-BLUE CAPSULE, YELLOW POWDER |
|---|
| Note | |
|---|
| License Owner | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Manufacturer | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Country | LAO PDR |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 L 0904/22 |
|---|
| FDD Registration Date | 2022-03-30 |
|---|
| Expiry Date | 2025-03-29 |
|---|
